Huazi Industrial announced that the company plans to invest 10 million yuan to establish a wholly-owned subsidiary Henglu Biotech to promote the “innovation-driven, diversified layout, and industrial upgrading” development strategy. The newly established subsidiary will use the existing technology platform to develop skincare products and lightweight meal replacement products, which will help lengthen the industrial chain and enhance the product value chain. There is no need to submit this investment to the shareholders' meeting for review. The funding source is self-raised by the company, and it will not adversely affect the company's financial and operating conditions.

Huazi Industrial announced that the company plans to invest 10 million yuan to establish a wholly-owned subsidiary Henglu Biotech to promote the “innovation-driven, diversified layout, and industrial upgrading” development strategy. The newly established subsidiary will use the existing technology platform to develop skincare products and lightweight meal replacement products, which will help lengthen the industrial chain and enhance the product value chain. There is no need to submit this investment to the shareholders' meeting for review. The funding source is self-raised by the company, and it will not adversely affect the company's financial and operating conditions.